SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
___________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of report (Date of earliest event reported)
June 22, 2010
 
 
VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)
 
 
Delaware
1-7598
94-2359345
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
 Identification No.)
 
 
3100 Hansen Way, Palo Alto, CA
94304-1030
(Address of Principal Executive Offices)
(Zip Code)
 
 
Registrant's telephone number, including area code
(650) 493-4000
 
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Item 7.01.
Regulation FD Disclosure
 
At a June 22, 2010 event, Scripps Health announced that it will be developing the Scripps Proton Therapy Center in San Diego, California (the “Scripps Center”) with partners including Advanced Particle Therapy LLC and Varian Medical Systems, Inc. (“Varian”).  Varian has entered into a purchase agreement valued at $88 million to supply Varian’s particle therapy system for the planned Scripps Center.  The agreement is subject to a contingency that financing for the Scripps Center be complete, and Varian will not book the order for this system until such financing is complete.  The Scripps Center will be operated by Scripps Health under the medical direction of the Scripps Clinic Medical Group.
 
2
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  Varian Medical Systems, Inc.  
     
       
 
By:
/s/ JOHN W. KUO  
  Name:    John W. Kuo  
 
Title:
Corporate Vice President, General Counsel and Secretary
  
       
 
Dated:  June 22, 2010
 
3